A novel selective γ-aminobutyric acid transport inhibitor demonstrates a functional role for GABA transporter subtype GAT2/BGT-1 in the CNS

The system of GABA transporters in neural cells constitutes an efficient mechanism for terminating inhibitory GABAergic neurotransmission. This transport system is an important therapeutical target in epileptic disorders, but potentially also in other neurological disorders. Thus, selective intervention in GABA uptake has been the subject of extensive research for several decades. In a series of lipophilic diaromatic derivatives of (RS)-3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO), N-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-hydroxy-4-(methylamino)-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol (EF1502) turned out to be an equipotent inhibitor at the mouse transporters GAT1 and GAT2 (BGT-1) but inactive at GAT3 and GAT4. This novel pharmacological profile among GABA uptake inhibitors prompted a thorough investigation of the in vivo properties of this compound. These investigations have for the first time demonstrated a functional role for GABA transporter subtype GAT2/BGT-1, which points to the therapeutic relevance of inhibiting this transporter subtype. An overview of the development and characterisation of EF1502 is presented here.

[1]  C. Thomsen,et al.  1‐(3‐(9H‐Carbazol‐9‐yl)‐1‐propyl)‐4‐(2‐methoxyphenyl)‐4‐piperidinol, a novel subtype selective inhibitor of the mouse type II GABA‐transporter , 1997, British journal of pharmacology.

[2]  A. Schousboe,et al.  Glutamate and gaba receptors and transporters : structure,function and pharmacology , 2001 .

[3]  A. Schousboe,et al.  Inhibition of the high-affinity, net uptake of GABA into cultured astrocytes by β-proline, nipecotic acid and other compounds , 1978, Brain Research.

[4]  Arne Schousboe,et al.  GABA transporters: functional and pharmacological properties , 2001 .

[5]  P. Suzdak,et al.  The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate. , 1993, Journal of medicinal chemistry.

[6]  Arne Schousboe,et al.  Correlation between Anticonvulsant Activity and Inhibitory Action on Glial γ-Aminobutyric Acid Uptake of the Highly Selective Mouse γ-Aminobutyric Acid Transporter 1 Inhibitor 3-Hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and ItsN-Alkylated Analogs , 2002, Journal of Pharmacology and Experimental Therapeutics.

[7]  Scott Slough,et al.  First Demonstration of a Functional Role for Central Nervous System Betaine/γ-Aminobutyric Acid Transporter (mGAT2) Based on Synergistic Anticonvulsant Action among Inhibitors of mGAT1 and mGAT2 , 2005, Journal of Pharmacology and Experimental Therapeutics.

[8]  A. Schousboe,et al.  Kinetic Characterization of Inhibition of γ‐Aminobutyric Acid Uptake into Cultured Neurons and Astrocytes by 4,4‐Diphenyl‐3‐Butenyl Derivatives of Nipecotic Acid and Guvacine , 1988, Journal of neurochemistry.

[9]  L. Borden.  GABA TRANSPORTER HETEROGENEITY: PHARMACOLOGY AND CELLULAR LOCALIZATION , 1996, Neurochemistry International.

[10]  T. Branchek,et al.  Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3. , 1994, Journal of medicinal chemistry.

[11]  B. Metcalf,et al.  4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. , 1977, European journal of biochemistry.

[12]  M. Neal,et al.  Cis-3-aminocyclohexanecar☐ylic acid: a substrate for the neuronal GABA transport system , 1977, Brain Research.

[13]  W. Haefely.  Central Actions of Benzodiazepines: General Introduction , 1978, British Journal of Psychiatry.

[14]  P. Suzdak,et al.  NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization. , 1992, European journal of pharmacology.

[15]  H. Meltzer,et al.  Psychopharmacology : the third generation of progress , 1987 .

[16]  P. Krogsgaard‐Larsen,et al.  GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects. , 2000, Current pharmaceutical design.

[17]  T. Branchek,et al.  Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. , 1994, European journal of pharmacology.

[18]  L. Yunger,et al.  Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice. , 1984, The Journal of pharmacology and experimental therapeutics.

[19]  A. Schousboe,et al.  Effects of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazol (exo-THPO) and its N-substituted analogs on GABA transport in cultured neurons and astrocytes and by the four cloned mouse GABA transporters , 2003, Neurochemistry International.

[20]  C. Kaiser,et al.  Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake , 1985 .

[21]  A. Schousboe,et al.  Heterocyclic GABA analogues as new selective inhibitors of astroglial GABA transport , 1981 .

[22]  Arne Schousboe,et al.  Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol analogues. , 2005, Bioorganic & medicinal chemistry.

[23]  P. Suzdak,et al.  A Review of the Preclinical Pharmacology of Tiagabine: A Potent and Selective Anticonvulsant GABA Uptake Inhibitor , 1995, Epilepsia.

[24]  D. R. Curtis,et al.  A new class of GABA agonist , 1977, Nature.

[25]  A. Schousboe,et al.  Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission , 2004, Neurochemistry International.

[26]  P. Krogsgaard‐Larsen,et al.  INHIBITION OF GABA UPTAKE IN RAT BRAIN SLICES BY NIPECOTIC ACID, VARIOUS ISOXAZOLES AND RELATED COMPOUNDS , 1975, Journal of neurochemistry.

[27]  J. Barker,et al.  Pentobarbital selectively enhances GABA-mediated post-synaptic inhibition in tissue cultured mouse spinal neurons , 1976, Brain Research.

[28]  D. R. Curtis,et al.  STRUCTURE AND BIOLOGICAL ACTIVITY OF A SERIES OF CONFORMATIONALLY RESTRICTED ANALOGUES OF GABA , 1975, Journal of neurochemistry.

[29]  C. Adkins,et al.  α4β3δ GABAAReceptors Characterized by Fluorescence Resonance Energy Transfer-derived Measurements of Membrane Potential* , 2001, The Journal of Biological Chemistry.

[30]  A. Guidotti,et al.  New concepts on the mechanism of action of benzodiazepines. , 1975, Life sciences.

[31]  L. Iversen,et al.  Uptake and metabolism of γ-aminobutyric acid by neurones and glial cells , 1975 .

[32]  P. Suzdak,et al.  (R)‐N‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier , 1990, Journal of neurochemistry.

[33]  A. Schousboe,et al.  Selective inhibitors of glial GABA uptake: synthesis, absolute stereochemistry, and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues. , 1999, Journal of medicinal chemistry.

[34]  A. Schousboe,et al.  Transport and Metabolism of 7‐Aminobutyric Acid in Neurons and Glia: Implications for Epilepsy , 1983, Epilepsia.

[35]  Joshua W. Miller,et al.  Cloned Sodium- (and Chloride-) Dependent High-Affinity Transporters for GABA, Glycine, Proline, Betaine, Taurine, and Creatine , 1997 .